Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and C...
12:00 ETUSA Cell Therapy Manufacturing Market Highlights Lonza Group as Global Market Reaches USD 23.2 Billion by 2036 at 14.1% CAGR | Future Market Insights
Lonza Group Ltd (LONN) Gets a Buy from Bernstein
Lonza H1 Results Climb, Lifts FY26 CORE EBITDA Margin View, Backs Sales Growth Forecast
LONN: Sales and margins surged, outlook raised, and a major business divestment was completed
Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG
Jefferies Sticks to Its Buy Rating for Lonza Group Ltd (LONN)